Report #2884095

Received Feb 4, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RVX	ROTAVIRUS (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	UNK	—

Symptoms (1)

Pruritus

Symptom narrative

itching; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pruritus in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced pruritus (Verbatim: itching). The outcome of the pruritus was not reported. It was unknown if the reporter considered the pruritus to be related to RSV vaccine. It was unknown if the company considered the pruritus to be related to RSV vaccine. Additional Information: GSK Receipt Date: 26-JAN-2026 This case was reported by a patient via interactive digital media. The batch number was not provided, and unable to contact the reporter.